01/05/2026 05:10
|
Medical, Health & Aged Care
SYDNEY, May 01, 2026 (GLOBE NEWSWIRE) -- EnGeneIC Limited today announced that the first patient has been dosed in its clinical trial evaluating EnGeneIC’s investigational EGFR-targeted EDV™...